SORL1 and Alzheimer disease: Potentially, impaired SORLA activity, as seen with some AD‐associated SORL1 variants (Holstege et al. 2023; Holstege et al. 2017; Holstege et al. 2022), may exacerbate pathology by reducing protective microglial immune responses.